DYADIC INTERNATIONAL INC Earnings Per Share (Diluted)
DYADIC INTERNATIONAL INC (DYAI) reported Earnings Per Share (Diluted) of -$0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-12
- DYADIC INTERNATIONAL INC earnings per share, diluted for the quarter ending 2026-06-30 was -$0.06.
- DYADIC INTERNATIONAL INC earnings per share, diluted for the quarter ending 2026-03-31 was -$0.05.
- DYADIC INTERNATIONAL INC earnings per share, diluted for the quarter ending 2025-12-31 was -$0.06.
- DYADIC INTERNATIONAL INC earnings per share, diluted for the quarter ending 2025-09-30 was -$0.06.
- DYADIC INTERNATIONAL INC earnings per share, diluted for fiscal 2025 was -$0.23.
- DYADIC INTERNATIONAL INC earnings per share, diluted for fiscal 2024 was -$0.20.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.06 10-Q · filed 2026-08-12 | -$0.11 10-Q · filed 2026-08-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-13 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.23 10-K · filed 2026-03-25 |
| 2025-09-30 | -$0.06 10-Q · filed 2025-11-12 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.17 10-Q · filed 2025-11-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.06 10-Q · filed 2026-08-12 | -$0.13 10-Q · filed 2026-08-12 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.07 10-Q · filed 2026-05-13 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2024-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.20 10-K · filed 2026-03-25 |
| 2024-09-30 | -$0.01 10-Q · filed 2025-11-12 | -$0.08 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.15 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$0.07 10-Q · filed 2025-08-13 | -$0.14 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |